| 1 |
29467878 | Parthenolide facilitates apoptosis and reverses drug-resistance of human gastric carcinoma cells by inhibiting the STAT3 signaling pathway. | 2018 Mar |
1 |
| 2 |
28423582 | Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway. | 2017 Apr 4 |
1 |
| 3 |
22324945 | Interleukin-6 upregulates expression of ADAMTS-4 in fibroblast-like synoviocytes from patients with rheumatoid arthritis. | 2012 Feb |
2 |
| 4 |
21413021 | Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation. | 2011 Jun |
4 |
| 5 |
17208315 | Signaling pathways implicated in oncostatin M-induced aggrecanase-1 and matrix metalloproteinase-13 expression in human articular chondrocytes. | 2007 Mar |
1 |
| 6 |
17385713 | Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: parthenolide targets JAK1 activation by generating ROS. | 2007 Aug |
4 |
| 7 |
17341611 | Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. | 2006 Dec |
1 |
| 8 |
15286701 | Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase. | 2004 Sep 23 |
1 |
| 9 |
10623619 | Parthenolide inhibits activation of signal transducers and activators of transcription (STATs) induced by cytokines of the IL-6 family. | 2000 Jan 7 |
1 |